Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tirzepatide in Endometrial Carcinoma: NCT07065552 Clinical Landscape Report 2026
15 October 2026
NCT07065552 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Muscle Invasive Bladder Urothelial Carcinoma: NCT07061964 Clinical Landscape Report 2026
15 October 2026
NCT07061964 clinical landscape for Muscle Invasive Bladder Urothelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and developmen…
9 min read
Etoposide in Acute Myeloid Leukemia: NCT07059975 Clinical Landscape Report 2026
15 October 2026
NCT07059975 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gemcitabine Hydrochloride in Non-Muscle Invasive Bladder Urothelial Carcinoma: NCT07064863 Clinical Landscape Report 2026
15 October 2026
NCT07064863 clinical landscape for Non-Muscle Invasive Bladder Urothelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Lidocaine in Dermatitis, Atopic: NCT07067541 Clinical Landscape Report 2026
15 October 2026
NCT07067541 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Orelabrutinib in Multiple Sclerosis, Primary Progressive: NCT07067463 Clinical Landscape Report 2026
15 October 2026
NCT07067463 clinical landscape for Multiple Sclerosis, Primary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
LNK01004 in Dermatitis, Atopic: NCT07071610 Clinical Landscape Report 2026
15 October 2026
NCT07071610 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BCMA CAR-T Cell(Xuzhou Medical University) in Multiple Myeloma: NCT07070960 Clinical Landscape Report 2026
15 October 2026
NCT07070960 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GV20-0251 in MSS/pMMR/MSI-L Colorectal Carcinoma: NCT07070518 Clinical Landscape Report 2026
15 October 2026
NCT07070518 clinical landscape for MSS/pMMR/MSI-L Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
CJ-15314 in Moderate Atopic Dermatitis: NCT07073677 Clinical Landscape Report 2026
15 October 2026
NCT07073677 clinical landscape for Moderate Atopic Dermatitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Itraconazole in Acute Myeloid Leukemia: NCT07069933 Clinical Landscape Report 2026
15 October 2026
NCT07069933 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GC-012F in Multiple Myeloma: NCT07073547 Clinical Landscape Report 2026
15 October 2026
NCT07073547 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.